Bicyclic cytarabine analogues: synthesis and investigation of antitumor properties of novel, 6-aryl- and 6-alkyl-3H-pyrrolo[2,3-d] pyrimidin-2(7H)-one arabinosides

被引:5
作者
Mieczkowski, Adam [1 ]
Makowska, Malgorzata [1 ]
Sekula, Justyna [1 ]
Tomczyk, Ewelina [1 ]
Zalewska, Ewa [1 ]
Nasulewicz-Goldeman, Anna [2 ]
Wietrzyk, Joanna [2 ]
机构
[1] Polish Acad Sci, Inst Biochem & Biophys, PL-02106 Warsaw, Poland
[2] Polish Acad Sci, Inst Immunol & Expt Therapy, PL-53114 Wroclaw, Poland
关键词
Bicyclic pyrimidine nucleoside analogues (BCNAs); Arabinonucleosides; Cytarabine analogues; Cytotoxicity; VARICELLA-ZOSTER-VIRUS; SOLID-SUPPORTED SYNTHESIS; ACID RELATED-COMPOUNDS; NUCLEOSIDE ANALOGS; SELECTIVE-INHIBITION; BIOLOGICAL-ACTIVITY; CYCLOCYTIDINE; PYRIMIDINE; POTENT; PHARMACOKINETICS;
D O I
10.1016/j.tet.2015.09.015
中图分类号
O62 [有机化学];
学科分类号
070303 ; 081704 ;
摘要
A series of sixteen hitherto unknown Cytarabine analogues bearing a bicyclic 3H-pyrrolo[2,3-d]pyr-imidin-2(7H)-one base modified with aryl, pyridyl, benzyl and alkyl substituents was prepared in a straightforward approach. This is the one of the few examples of the synthesis of pyrrolo[2,3-d]pyrimidin-2(7H)-one nucleosides and the first example of pyrrolo[2,3-d]pyrimidin-2(7H)-one nucleosides possessing arabinose moiety. For the first time, the conversion of the furopyrimidine arabinoside products to a series of novel pyrrolopyrimidines by ammonolysis reaction was thoroughly investigated using aqueous and methanolic reaction conditions under classical and micro-wave heating. This approach resulted in a small library of compounds, which were evaluated for their antiproliferative properties against HL-60 and Jurkat E6.1 cell lines. All synthesized compounds exhibited a weaker cytotoxic effect in comparison to the mother compound. Of all the tested compounds, the derivative bearing a 4-n-pentylphenyl substituent exhibited the highest antiproliferative activity. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:8454 / 8461
页数:8
相关论文
共 45 条
  • [1] Synthesis, cytotoxicity and antibacterial activity of new esters of polyether antibiotic - salinomycin
    Antoszczak, Michal
    Popiel, Katarzyna
    Stefanska, Joanna
    Wietrzyk, Joanna
    Maj, Ewa
    Janczak, Jan
    Michalska, Greta
    Brzezinski, Bogumil
    Huczynski, Adam
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 76 : 435 - 444
  • [2] AOSHIMA M, 1977, CANCER RES, V37, P2481
  • [3] CYTARABINE AND NEUROLOGIC TOXICITY
    BAKER, WJ
    ROYER, GL
    WEISS, RB
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (04) : 679 - 693
  • [4] BURCHENAL JH, 1977, CANCER RES, V37, P4098
  • [5] NUCLEIC-ACID RELATED-COMPOUNDS .40. SYNTHESIS AND BIOLOGICAL-ACTIVITIES OF 5-ALKYNYLURACIL NUCLEOSIDES
    DECLERCQ, E
    DESCAMPS, J
    BALZARINI, J
    GIZIEWICZ, J
    BARR, PJ
    ROBINS, MJ
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1983, 26 (05) : 661 - 666
  • [6] Synthesis and antiviral and cytostatic evaluations of the new C-5 substituted pyrimidine and furo[2,3-d] pyrimidine 4′,5′-didehydro-L-ascorbic acid derivatives
    Gazivoda, Tatjana
    Sokcevic, Mario
    Kralj, Marijeta
    Suman, Lidija
    Pavelic, Kresimir
    De Clercq, Erik
    Andrei, Graciela
    Snoeck, Robert
    Balzarini, Jan
    Mintas, Mladen
    Raic-Malic, Silvana
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (17) : 4105 - 4112
  • [7] Clinical pharmacokinetics of cytarabine formulations
    Hamada, A
    Kawaguchi, T
    Nakano, M
    [J]. CLINICAL PHARMACOKINETICS, 2002, 41 (10) : 705 - 718
  • [8] Hirayama H, 1974, PHARMACOMETRICS, V8, P353
  • [9] HIRAYAMA H, 1974, PHARMACOMETRICS, V8, P1693
  • [10] Hirayama H, 1972, PHARMACOMETRICS, V6, P1255